Favourable credit rating by Dun & Bradstreet

Published 30.11.2010

Dun & Bradstreet have recently launched their evaluation of the credit status of Marine Biochemicals and have rated us AA based on the financial result 2009 reported for Marine Biochemicals since its establishment on 3 June 2009 until year end 2009.

Let us just for the record recap the annual result for the full year including the first half year under Biotec Pharmacon: Total revenues: 17.6 mNOK and EBITDA: 8,4 mNOK.